@toebubble4
Active 1 year, 6 months ago-
Bennedsen Bloom posted an update 1 year, 6 months ago
The current therapeutic approach in Waldenström’s macroglobulinemia (WM) is being driven by insights in disease biology and genomic landscape. Bruton’s tyrosine kinase (BTK) plays a key role in signaling pathways for the survival of WM clone. BTK inhibition has changed the treatment landscape of the disease. Ibrutinib has resulted in deep and…[Read more]
-
Bennedsen Bloom posted an update 1 year, 6 months ago
To consider sepsis-induced acute kidney injury, renal functional biomarkers and histopathological changes was assessed.
GA treatment significantly improved survival rate at doses of 1, and 2mg/kg. Survival improvement was accompanied by remarkable reduction in the pro-inflammatory cytokines and enhanced production of IL-10. GA showed to…[Read more]
-
Bennedsen Bloom became a registered member 1 year, 6 months ago
